30
Participants
Start Date
April 19, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
March 31, 2026
Curcumin
Patients will receive capsules with curcumin C3 (Sabinsa Corp, NJ, USA) containing 1g of curcumin. They will be instructed to consume orally 1 capsule with breakfast for group 1, 1 capsule with each meal for group 3, and 2 capsules with each food for group 5.
Curcumin + Piperine
Patients will receive capsules with curcumin C3 (Sabinsa Corp, NJ, USA) containing 1g of curcumin additioned with 5 mg of piperine. They will be instructed to consume orally 1 capsule with breakfast for group 2, 1 capsule with each meal for group 4, and 2 capsules with each meal for group 6.
RECRUITING
Instituto Nacional de Cancerología, Mexico City
Sabinsa Corporation
INDUSTRY
National Institute of Cancerología
OTHER_GOV